Keel Point »

Vertex Pharmaceuticals Incorporated shares owned by Keel Point

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Keel Point from 13F filings

Historical chart of Keel Point investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Keel Point consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Keel Point

Quarter filed Position value Share count Share price at filing
2026-03-31 $423k 947 446.37
2025-12-31 $551k 1.2k 453.22
2025-09-30 $443k 1.1k 391.64
2025-06-30 $573k 1.3k 445.20
2025-03-31 $574k 1.2k 484.82
2024-12-31 $389k 967 402.70
2024-09-30 $655k 1.4k 465.08
2024-06-30 $664k 1.4k 467.59
2024-03-31 $427k 1.0k 418.01
2023-12-31 $230k 564 406.89

More positions owned by Keel Point

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Netflix (NFLX)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Rus 1000 Etf (IWB)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Msci Eafe Etf (EFA)
Apple (AAPL)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
NVIDIA Corporation (NVDA)
Spdr Series Trust State Street Spd (SPYM)
Amazon (AMZN)
Tesla Motors (TSLA)
Ishares Tr Rus 1000 Grw Etf (IWF)

View all positions for Keel Point

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Loomis, Sayles and
Alliancebernstein
Wellington Management Company
Victory Capital Management
Morgan Stanley
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated